Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size

British Journal of Clinical Pharmacology

Volumn 64, Issue 3, 2007, Pages 328-334

  Esposito Festen, J E ^a   Zanen, P ^b   Tiddens, H A W M ^a   Lammers, J W J ^b  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Asthma; Monodisperse aerosols; Steroids

Indexed keywords

BECLOMETASONE DIPROPIONATE; SALBUTAMOL;

ADULT; AEROSOL; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; FEMALE; GASTROINTESTINAL ABSORPTION; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; PARTICLE SIZE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AEROSOLS; ANTI-ASTHMATIC AGENTS; AREA UNDER CURVE; ASTHMA; BECLOMETHASONE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARTICLE SIZE; SINGLE-BLIND METHOD;

EID: 34548014959     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.02894.x     Document Type: Article

References (29)

1. Timsina MP, Martin GP, Marriott C, Ganderton D, Yianneskis M. Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm 1994 101 : 1 13.
2. Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME. Effect of aerosolized recombinant human DNAase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 1994 331 : 637 42.
3. Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, Schidlow DV, Wilmott RW, Astley SJ, McBurnie MA, Wentz K, Smith AL. Efficacy of aerosolized tobromycin in patients with cystic fibrosis. N Engl J Med 1993 328 : 1740 6.
4. Laube BL, Georgopoulos A, Adams GK, 3rd. Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients. JAMA 1993 269 : 2106 9.
5. Laube BL, Benedict GW, Dobs AS. Time to peak insulin level, relative bioavailability, and effect of site of deposition of nebulized insulin in patients with noninsulin-dependent diabetes mellitus. J Aerosol Med 1998 11 : 153 73.
6. Harsch IA, Hahn EG, Konturek PC. Syringe, pen, inhaler - the evolution of insulin therapy. Med Sci Monit 2001 7 : 833 6.
7. Suarez S, Hickey AJ. Drug properties affecting aerosol behavior. Respir Care 2000 45 : 652 66.
8. Howarth PH. Why particle size should affect clinical response to inhaled therapy. J Aerosol Med 2001 14 (Suppl 1 S27 34.
9. Laube BL, Jashnani R, Dalby RN, Zeitlin PL. Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate. Chest 2000 118 : 1069 76.
10. O'Riordan TG, Walser L, Smaldone GC. Changing patterns of aerosol deposition during methacholine bronchoprovocation. Chest 1993 103 : 1385 9.
11. Macklem PT. The physiology of small airways. Am J Respir Crit Care Med 1998 157 : S181 3.
12. Laube BL, Edwards AM, Dalby RN, Creticos PS, Norman PS. The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma. J Allergy Clin Immunol 1998 101 : 475 83.
13. Iles R, Lister P, Edmunds AT. Crying significantly reduces absorption of aerosolised drug in infants. Arch Dis Child 1999 81 : 163 5.
14. Usmani OS, Biddiscombe MF, Nightingale JA, Underwood SR, Barnes PJ. Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols. J Appl Physiol 2003 95 : 2106 12.
15. 2-agonist particle size. Am J Respir Crit Care Med 2005 172 : 1497 504.
16. 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction. Thorax 1996 51 : 977 80.
17. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995 152 : S77 S121.
18. Ijsebaert JC, Geerse KB, Marijnissen JC, Lammers JW, Zanen P. Electro-hydrodynamic atomization of drug solutions for inhalation purposes. J Appl Physiol 2001 91 : 2735 41.
19. Daley-Yates PT, Price AC, Sisson JR, Pereira A, Dallow N. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man. Br J Clin Pharmacol 2001 51 : 400 9.
20. CPMP. Note for guidance on the investigation of bioavailability and bioequivalence. http://www.emea.org.
21. Bennett WD, Brown JS, Zeman KL, Shu-Chieh H, Scheuch G, Sommerer K. Targeting delivery of aerosols to different lung regions. J Aerosol Med 2002 15 : 179 88.
22. Bennett WD, Scheuch G, Zeman KL, Brown JS, Kim C, Heyder J, Stahlhofen W. Bronchial airway deposition and retention of particles in inhaled boluses: effect of anatomic dead space. J Appl Physiol 1998 85 : 685 94.
23. Bennett WD, Scheuch G, Zeman KL, Brown JS, Kim C, Heyder J, Stahlhofen W. Regional deposition and retention of particles in shallow, inhaled boluses: effect of lung volume. J Appl Physiol 1999 86 : 168 73.
24. Newman SP, Pavia D, Garland N, Clarke SW. Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis Suppl 1982 119 : 57 65.
25. Agertoft L, Laulund LW, Harrison LI, Pedersen S. Influence of particle size on lung deposition and pharmacokinetics of beclometasone dipropionate in children. Pediatr Pulmonol 2003 35 : 192 9.
26. Harrison LI, Kurup S, Chen LZ, Ekholm BP, Wighton TG, Shapiro GG. Pharmacokinetic comparison of beclometasone dipropionate extrafine aerosol from two inhaler devices in children with asthma. Eur J Clin Pharmacol 2002 58 : 191 5.
27. Heyder J, Gebhart J, Rudolph G, Schiller CF, Stahlhofen W. Deposition of particles in the human respiratory tract in the size range 0.005-15 microns. J Aerosol Sci 1986 17 : 811 25.
28. Harrison LI, Soria I, Cline AC, Ekholm BP. Pharmacokinetic differences between chlorofluorocarbon and chlorofluorocarbon-free metered dose inhalers of beclomethasone dipropionate in adult asthmatics. J Pharm Pharmacol 1999 51 : 1235 40.
29. Harrison LI, Colice GL, Donnell D, Soria I, Dockhorn R. Adrenal effects and pharmacokinetics of CFC-free beclometasone dipropionate: a 14-day dose-response study. J Pharm Pharmacol 1999 51 : 263 9.